Search

Your search keyword '"De Luca Giacomo"' showing total 689 results

Search Constraints

Start Over You searched for: Author "De Luca Giacomo" Remove constraint Author: "De Luca Giacomo"
689 results on '"De Luca Giacomo"'

Search Results

1. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

8. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study

11. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

13. Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report

15. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

18. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis

19. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature

20. Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases

24. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

25. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

26. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

27. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

30. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement

32. Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight.

33. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

36. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

39. Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study

42. Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study

43. Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life

44. Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter 'SPRING' (Systemic Sclerosis Progression InvestiGation) Registry

45. Does the impact of COVID-19 on patients with systemic sclerosis change over time?

46. Does the impact of COVID-19 on patients with systemic sclerosis change over time?

47. Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey

49. Arrhythmias in myocarditis: State of the art

Catalog

Books, media, physical & digital resources